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The effects of Wasabia japonica (WJ) were investigated in vitro and in vivo for their anti-oxidant
and anti-hypercholesterolemic activities. It was found that the aqueous extracts of WJ leaves
(WJL) had strong scavenging activities towards 1,1-Diphenyl-2-picryhydrazyl (DPPH) and
nitric oxide (NO) free radicals in cell free systems. WJL also inhibited NO production and the
expressions of inducible NO synthase (iNOS) mRNA and enzyme protein, determined by
Griess reactions, RT-PCR or Western blotting respectively in Lipopolysaccharide (LPS)-
stimulated RAW 264.7 macrophages cells. The anti-hypercholesterolemic effects of WJ diet
were investigated in hypercholesterolemia rats. Sprague-Dawley rats were divided into four
groups and were fed with either normal diet (Group 1), or diet containing 1%(w/w) cholesterol
(Groups 2, 3 and 4). After 4 weeks, Group 2 was changed to normal diet, Groups 3 and 4 were
changed to the diet containing 5% WJ leaf and or 5% WJ root, respectively. 3 weeks after WJ
diets, Serum HDL-cholesterol levels were significantly increased in WJ diet groups compared
with the normal diet hypercholesterolemia rats. In contrast, the serum LDL-cholesterol levels
and liver xanthine oxidase (XO) activity in WJ diet groups were significantly decreased. The
results indicate that the WJ extracts have significant anti-oxidant activities, and the WJ diet
exhibited anti-hypercholesterolemic action in high cholesterol diet rats, which was companied
with modulations of cholesterol metabolism and decrease in liver XO activity.
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Introduction
Wasabia japonica (WJ), also known as ‘wasabi’, is one of
the popular spices in many Asian countries, especially in
Korea and Japan. It has been used to treat rheumatic
arthralgia, through promoting blood circulation and
alleviation of pain (1). WJ contains several isothiocyanate
(2), which are known for having anti-microbial, fungicidal,
pesticidal activities as well as anti-carcinogenic effect (2–4).
However, there are few reports on the anti-oxidant
activities and anti-hypercholesterolemic effects of WJ,
although it is well known that many plants have anti-
oxidant and free radical scavenging activities (5–7).
Free radical oxidative stress, usually resulting from defi-
cient natural anti-oxidant defenses (8), has been implicated
in the pathogenesis of a wide variety of clinical disorders,
such as the degenerative diseases (9), aging (10) and the
progressive decline in the immune functions (11). Nitric
oxide (NO) is one of the reactive oxygen species (ROS),
and plays an important role in diverse physiological pro-
cesses, including vasodilatation, neurotransmission and
immune responses (12). The pathological roles of NO have
been implicated in a wide range of inflammatory diseases,
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such as sepsis, arthritis, multiple sclerosis and systemic
lupus erythematosus (13). It has been also reported that
hypercholesterolemia is increased free radical production
and reduced free radical scavenging effect (14). Therefore,
certain natural products with anti-oxidant activities may
have potential anti-hypercholesterolemia actions.
In this study, we investigated the effects of WJ extracts
on the inhibition of 1,1-Diphenyl-2-picryhydrazyl (DPPH)
and NO formation in cell free system, as well as the
expressions of iNOS mRNA and enzyme protein in RAW
264.7 murine macrophage cells. Furthermore, we studied
the anti-hypercholesterolemic effects of WJ diet in
hypercholesterolemia rats in vivo.
Methods
Preparation of WJ
WJ used in this study was supplied and identified by
Dr Man Jong Bae from the Efficacy and Safety Research
Center for Traditional Oriental Medicines, Kyungbuk
Technopark, South Korea. The voucher specimen
(No. ESRC 020303) was deposited in the herbarium at
the above mentioned research center. The root and leaf
of WJ (400 g) were extracted three times with 1500ml
of ethanol and distilled water. The extracts were then
evaporated in vacuo to obtain WJ leave aqueous extract
(WJL, 8.34 g), WJ leave ethanol extract (WJLE, 7.71 g),
WJ root aqueous extract (WJR, 6.56 g) and WJ root
ethanol extract (WJRE, 7.40 g), respectively.
DPPH Scavenging Assay
The hydrogen-donating ability of each extract was exam-
ined according to the method previously described (6,15)
in the presence of a DPPH stable radical. The extracts
and positive control Vitamin C were diluted in methanol
to prepare a sample solution (800, 400, 200 and
100 mgml1). A total of 500ml of the sample solution
was then mixed with 500 ml of 5104M DPPH solution
for 10 s. Absorbance of the methanolic DPPH tincture
was measured with a spectrophotometer spectrophot-
ometer (DU530, Beckman Coulter, CA, USA) at 517 nm.
Nitric Oxide Scavenging Assay
Nitric oxide generated from sodium nitroprusside was
measured as described by Marcocci et al. (16) using the
Griess reagent. Various concentrations (800, 400, 200 and
100 mgml1) of the extracts (2ml) and 25mM sodium
nitroprusside (0.5ml) were incubated at 25C for 150min.
After incubation, samples (0.5ml) and 0.5ml of Griess
reagent (1% sulphanilamide, 2% o-phosphoric acid and
0.1% naphthyl ethylenediamine dihyrochloride) were incu-
bated at room temperature for 10min. The absorbance
of the chromophore formed was measured with a
spectrophotometer (DU530, Beckman Coulter, CA,
USA) at 540 nm.
Cell Culture
Murine macrophage RAW 264.7 cells were obtained from
the American Type Culture Collection (ATCC; TIB71,
Maryland, USA). The cells were maintained in complete
Dulbeco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% heat-inactivated Fetal Bovine Serum
(FBS), 1% antibiotics/anti-mycotics (100Uml1 of peni-
cillin, 2.5 mgml1 of amphotericin D and 100 mgml1 of
streptomycin) and 1.5% sodium bicarbonate at 37C in a
humidified 5% CO2 atmosphere. Cells were plated at a
density of 1106 cells/well in a 60mm dish, and allowed to
attach for 2 h. For stimulation, the medium was replaced
with 1% FBS contained DMEM, and the cells were then
stimulated with 1 mgml1 of LPS in the presence or
absence of various concentrations of WJL for 48 h.
Measurement of Nitrite
NO synthesis in cell culture was measured by a Griess
reagent according to the previous study (17). Briefly,
a 100 ml/well sample was incubated with an equal volume
of the Griess solution (1% sulfanilamide in 5% phos-
phoric acid+1% naphthylamide in distilled aqueous)
at room temperature for 10min. The absorbance was
measured with a micro Enzyme-Linked Immunosorbent
Assay (ELISA) reader at 540 nm. Nitrite was determined
by using sodium nitrite as the standard.
Total RNA Isolation and RT-PCR
Murine macrophage RAW 264.7 cells in the TRIzol
reagent were well homogenized and vortexed after a
1/10 volume of chloroform was added. After incubating
the mixture on ice for 15min, the samples were centri-
fuged at 12 000 r.p.m., for 15min at 4C. The aqueous
phase was transferred to a new 1.5ml micro centrifuge
tube. RNA from the aqueous phase was precipitated
by mixing it with the same volume of isopropyl alcohol,
and was centrifuged at 12 000 r.p.m. for 15min at 4C,
following 30min of incubation on ice. Precipitated RNA
pellets were washed once with 70% ethyl alcohol, and
were redissolved in DEPC-treated water (Quality Biolog-
ical Inc., Gaithersburg, MD, USA). RT reaction of 4 mg
of RNA was performed in a 20 mg RT reaction mixture
containing 0.5ml of MMLV reverse transcriptase
(200U ml1, Promega), 4.0 ml of 5MMLV RT buffer
(Promega), 2.0ml of dNTP mixture (10mM, BM), 0.5 ml
of RNasin (RNase inhibitor, 40U ml1, Promega) and
2.0 ml of oligo dT (50 mM) in DEPC-treated water. The
reaction was performed under the conditions of 42C for
1 h and 95C for 5min. The cDNAs were amplified in
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a PCR with following primer sets: 50-GAC AAG CTG
CAT GTG ACA TC-30, 50-GCT GGT AGG TTC CTG
TTG TT –30 for iNOS. 50-CCA CCC AGA AGA CTG
TGG ATG GC-30, 50-CAT GTA GGC CAT GAG GTC
CAC CAC-30 for G3PDH. PCR was carried out with the
use of 1.0ml of RT products as templates: 94C for 3min
followed by 35 cycles of denaturation at 94C for 45 s,
annealing at 57C for 45 s, and elongation at 72C for
45 s. The last cycle was followed by a 10min extension
step at 72C. The amplified products were analyzed by
ethidium bromide-stained agarose gel electrophoresis.
Western Blotting
Cellular lysate were prepared by suspending 1106 cells
in 100 ml of lysis buffer (50mM Tris–Cl, 25mM EDTA,
650mM NaCl, 5% Triton X-100, 100X PMSF, a 100X
protease inhibitor cocktail, 5X lysis buffer). Proteins in
the cell lysates were then separated by a 12% SDS-
polyacrylamide gel electrophoresis and transferred to
a Protran nitrocellulose membrane (S&S, GmbH,
Germany). The membrane was then blocked with 5%
skim milk in PBS-Tween-20 for 1 h at room temperature
and then incubated with an anti-iNOS antibody
(Transduction lab, Lexington, KY, USA). After washing
in PBS-Tween-20 three times, the blot was incubated with
a secondary antibody. Detection of specific proteins was
carried out with an ECL Western blotting kit (Amersham
Pharmacia Biotech, USA) according to the manufacture’s
instructions.
In Vivo Experiments
Male Sprague-Dawley rats (180–200 g) were supplied
from Dae-Han Laboratory Animal Research Center Co.
(Choongbook, Korea) and maintained on a 12 h light/
dark cycle. Purina Rodent Chow (Bio Genomics, Inc.,
Korea) and tap water provided ad libitum. All procedures
relating to animals and their care were in accordance
with the institution guideline for animal research.
Animals were divided into four groups comprising six
rats in each group. Group 1 served as the healthy control
groups and was given the normal diet and the other
Groups (2, 3 and 4) received a 1% cholesterol diet. After
4 weeks, the Groups 1 and 2 received a normal diet,
Group 3 received a normal diet containing 5% leaf
powder of WJ and Group 4 received a normal diet
containing 5% root powder of WJ.
After 3 weeks treatment, all the animals were sacrificed
and blood was collected by decapitation to determine
the levels of total cholesterol, HDL-cholesterol and LDL-
cholesterol. The liver was removed, weighed and homo-
genized with POLYTRON PT-MR2100 (Kinematica,
Swiss), in ice chilled in a 0.25M sucrose solution. The
suspension was centrifuged at 3000 r.p.m. at 4C for
10min, and the supernatant was used for the
determination of XO activity. The enzyme activity of
XO was determined according to the method of Della
Corte and Strip (18). The unit of enzyme activity was
expressed as nano moles of produced uric acid of 1mg
protein per min.
Statistical Analysis
One-way analysis of variance (ANOVA) was used to
evaluate the statistical significance of changes in all
indices as a function of dose and treatment, followed by
Duncan’s new multiple range test using P<0.05 as the
level of significance.
Results
Scavenging activity on DPPH and NO radicals
The scavenging activity of WJ extracts towards DPPH
and NO radicals were shown in Figs 1 and 2. A
concentration-dependent inhibition of DPPH and
NO radicals were observed for all WJ extracts tested.
At 800 mgml1 WJL inhibited DPPH generation by
67.5 2.4% and NO generation by 50.1 1.3%. On the
other hand, WJLE, at 800 mgml1, inhibited the DPPH
by 59.3 1.8% and NO by 45.8 3.1%. Among the
tested extracts, WJL showed a strong scavenging activity
towards DPPH and NO. Therefore, it was used for
further experiments.
NO Production in LPS-Stimulated Macrophages
As previously reported, LPS markedly induced NO pro-
duction in RAW 264.7 cells compared with unstimulated
cells. WJL significantly inhibited NO production in LPS-
stimulated RAW 264.7 cells in a dose-dependent manner
(Fig. 3). The observed effect was not due to a potential
Figure 1. DPPH scavenging activity of WJ extracts in vitro. Results
were expressed as percentage of inhibition, compared with the vehicle
control (means SEM, n=3). WJRE: root ethanol extract, WJR: root
aqueous extract, WJLE: leaf ethanol extract, WJL: leaf aqueous extract.
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cytotoxicity of WJL, since WJL showed no alteration of
cell viability (data not shown).
iNOS mRNA and iNOS Protein Expression
in RAW 264.7 Cells
WJL (200–800 mgml1) markedly decreased iNOS mRNA
expression in LPS-stimulated cells in a dose-dependent
manner (Fig. 4). Similarly WJL extract caused a dose-
dependent inhibition of expressions of iNOS enzyme
protein in Western blot analysis (Fig. 5). On the other
hand, a normal expression of HSP70 was observed with
same WJL concentrations.
Cholesterol Levels and Hepatic XO Activity in vivo
Compared with the hypercholesterolemia rats with
normal diet group (Group 2), HDL-cholesterol was
significantly (P<0.05, one-way ANOVA followed by
the Duncan’s new multiple range test) increased in the
hypercholesterolemia rats with 3 weeks 5% WJ leaf diet
(Group 3) or 5% WJ root diet (Group 4) (Table 1).
In contrast, LDL-cholesterol was significantly (P<0.05,
one-way ANOVA followed by the Duncan’s new multiple
range test) decreased in the Groups 3 and 4. However,
Group 4 has a significantly (P<0.05, one-way ANOVA
followed by the Duncan’s new multiple range test)
decreased LDL-cholesterol level compared with the
Group 2.
Figure 2. NO scavenging activity of WJ extracts in vitro. NO was
produced by sodium nitroprusside. Results were expressed as percentage
of inhibition, compared with the vehicle control (meansSEM, n=3).
WJRE: root ethanol extract, WJR: root aqueous extract, WJLE: leaf
ethanol extract, WJL: leaf aqueous extract.
Figure 3. Inhibition of NO production in lipopolysaccharide (LPS;
1 ugml1)-stimulated RAW 264.7 cells by WJL extract (WJL,
100–800 ugml1). RAW 264.7 cells were incubated with different con-
centrations of WJL in the absence of presence LPS for 24 h. The amount
of NO generated was measured by Griess reaction. The data are expressed
as mean SD of three separate experiments. *P<0.05 significantly
different from samples treat with LPS alone, analyzed by ANOVA test.
Figure 4. Effects of WJL extract (WJL, 200–800 ugml1) on iNOS
mRNA expression in LPS-stimulated RAW 264.7 cells. RAW 264.7
cells were stimulated with 1 ugml1 LPS in the presence or absence of
different concentrations of WJL for 24 h. iNOS mRNA was analyzed by
RT-PCR. G3PDH was used as control genes.
Table 1. Effects of WJ diets on the total blood cholesterol level
(mg dl1) in hypercholesterolemia rats
Treatment TC (mgdl1) HDL (mgdl1) LDL (mgdl1)
Group 1 58.8 3.9* 36.5 3.1 9.2 2.4*
Group 2 69.2 4.0 30.2 2.5 25.8 6.3
Group 3 66.9 3.0 38.1 1.6* 14.0 1.3
Group 4 64.9 2.9 41.7 1.6* 11.0 4.1*
Group 1: normal diet; Group 2: hypercholesterolemia rats+normal
diet; Group 3: hypercholesterolemia rats+normal diet containing 5%
WJ leaf; Group 4: hypercholesterolemia rats+normal diet containing
5% WJ root. Results are expressed as mean SEM, (n=5). *P<0.05
represent significantly different from hypercholesterolemia rats treated
with normal diet (Group 2), analyzed by ANOVA test.
Figure 5. Effects of WJL (200–800 ugml1) on the expression of iNOS
protein in LPS-stimulated RAW 264.7 cells. RAW 264.7 cells were
stimulated with 1 ugml1 LPS in the presence or absence of different
concentrations of WJL for 24 h. iNOS protein expression was analyzed
by Western blotting as described in the method. HSP70 was used as
a control genes.
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Hepatic XO activity was significantly (P<0.05, one-
way ANOVA followed by the Duncan’s new multiple
range test) decreased in both Groups 3 and 4, compared
with Group 2 (Table 2).
Discussion
The major findings of the present study are the demon-
stration of anti-oxidant activities of WJ extracts in vitro
and the discovery of an anti-hypercholesterolemic effect
of WJ diet in hypercholesterolemia rats.
WJ contains several kinds of isothiocyanate that
have been found to inhibit lung tumorigenesis (2). The
6-methlysulfinyhexyl isothiocyanate isolated from wasabi
was a potential inhibitor of human platelet aggregation
in vitro (19). In additional, wasabi ethanol extract has been
shown to inhibit cell growth of human monoblastic
leukemia U937 cells (20). Furthermore, Morimitsu (21)
reported that the anti-oxidant activities of WJ might
contribute to its anti-cancer effects. However, to our best
knowledge, no anti-hypercholesterolemic effects of WJ
have been demonstrated. In the present study, the scav-
enging activities on DPPH and NO radicals by aqueous
and ethanol extracts of WJ root and leaf were first
demonstrated in cell-free assays. The finding of strong
radical scavenging activity by WJL led us to investigate
further the biological significance of anti-oxidant of WJL
by measuring NO production and iNOS mRNA and
protein expressions in RAW 264.7 cells. As shown in the
present study, WJL significantly inhibited NO production,
as well as iNOS mRNA and protein expressions in LPS-
stimulated RAW 264.7 cells. Furthermore, there seems
a dose related correlation between the inhibition of NO
production and the inhibitions of iNOS mRNA and
iNOS protein expressions by WJL in RAW 264.7 cells.
The observed effect of WJL was unlikely due to any
cytotoxicity of WJL, since it did not affect the cell viability
or the normal expression of HSP70 under the experi-
mental conditions. The results suggest that WJL reduces
LPS-induced NO production through the inhibition of
iNOS mRNA expression, which leads to a decreased iNOS
protein expression. It is likely that this effect of WJL may
relate to its anti-oxidant activities, since it is known that
anti-oxidant molecules can decrease the gene expression of
iNOS (22–24). A number of plant materials have been
reported to inhibit NO production (12,16,23,25). Since
high levels of NO can induce host cell death and inflam-
matory tissue damage and iNOS-mediated NO production
has been involved in a variety of diseases or pathological
conditions such as infection and rheumatic disorders
(12,25), the observed effect of WJ may support the tradi-
tional use of WJ in the treatment of certain diseases such
as rheumatic arthralgia, or anti-microbial activities (2–4).
However, it still remains to be established whether the
clinical used doses of WJ can achieve therapeutic efficacy
in these conditions.
It has been reported that hypercholesterolemia
increased production of oxygen-free radical and raise
malondialdehyde level (26,27). Animals fed with high
cholesterol diet were shown with a depressed anti-oxidant
system and formation of free radical (14). Thus, it has
been suggested that the anti-oxidant effects may poten-
tially improve hypercholesterolemic status (28,29). The
present study has demonstrated for the first time that WJ
diet had a significant anti-hypercholesterolemic effect
in hypercholesterolemia rats in vivo. Three weeks after
WJ diet serum HDL-cholesterol level was increased while
at the same time the serum LDL-cholesterol level was
decreased. It is well know that the improvement of HDL
and LDL ratio benefits hypercholesterolemic conditions
(30–32). Furthermore, the liver XO activity in hypercho-
lesterolemic rats was also inhibited by WJ diet. XO is the
enzyme responsible for the formation of uric acid from
the purines hypoxanthine and xanthine. It serves as an
important biological source of oxygen-derived free
radicals that contribute to oxidative damage to living
tissues that are involved in many pathological processes
such as inflammatory, atherosclerosis, cancer and aging
(33–35). Therefore, WJ diet may improve the status of
hypercholesterolemia through the modulation of HDL,
LDL-cholesterol and anti-oxidant system.
In conclusion, the present study has clearly demonstrated
that WJ extracts tested exhibits free radical scavenging
activity towards NO and DHPP. Furthermore, in hyper-
cholesterolemia rats, WJ diet significantly increases blood
HDL-cholesterol but decreases blood LDL-cholesterol
levels. The liver XO activity was also decreased by WJ
diet. These results may provide a rational for using WJ leaf
extract or diet in certain conditions related with oxidative
stress or hypercholesterolemia.
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